EUVIMEDEUVIMED entdecken
Open Access

Contemporary Safety of Ultrasound Enhancing Agents in a Nationwide Analysis

Jordan B Strom iD, Sharon L Mulvagh iD, Thomas R Porter iD, Kevin Wei, Jessica L Stout, Michael L Main

Journal of the American Heart Association · 20.05.2025 · 14 (10)

DOI: 10.1161/jaha.124.039480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 20.05.2025. Verfasst von Jordan B Strom und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiovascular Division Beth Israel Deaconess Medical Center Boston MA USA. Hauptthemen laut MEDLINE: Echocardiography, Echocardiography, Stress, Fluorocarbons. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Ultrasound enhancing agents (UEAs) are an important diagnostic tool for transthoracic or stress echocardiography (TTE/SE) but recent concerns have been raised about their safety in reports from individual health systems. As such, we aimed to identify if UEAs for TTE/SE are associated with serious adverse events within 2 days of administration. Methods and Results All‐payor nationwide claims from 11.4 million insured individuals across the United States, 2018 to 2022 were used to evaluate rates of death, anaphylaxis, myocardial infarction, ventricular tachycardia, or cardiac arrest within 2 days of TTE/SE among adults receiving and not receiving UEAs. Of the 11 421 463 individuals included (mean age 57.5±16.2, 54.0% female, 46.2% White), a total of 500 073 (4.4%) received TTE/SE with UEAs. After propensity score matching, the odds of death were lower in those receiving UEAs (receipt versus nonreceipt, 0.02% versus 0.14%, odds ratio [OR], 0.23 [95% CI, 0.19–0.28], P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EchocardiographyEchocardiography, StressFluorocarbonsHumansFemaleMiddle AgedMaleUnited StatesAgedAnaphylaxisAdultMyocardial InfarctionHeart ArrestRisk Assessment

Stichwörter der Autor:innen

adverse eventsclaimsechocardiographysafetyultrasound enhancing agents

Substanzen

Fluorocarbons

Autor:innen und Institutionen

  • Department of Medicine, Cardiovascular Division Beth Israel Deaconess Medical Center Boston MA USA.
  • Richard A. and Susan F. Smith Center for Outcomes Research Beth Israel Deaconess Medical Center Boston MA USA.
  • Harvard Medical School Boston MA USA.
  • Dalhousie University Halifax Nova Scotia Canada.
  • University of Nebraska Omaha NE USA.
  • Oregon Health Sciences University Portland OR USA.

ORCID-Profile: Jordan B Strom, Sharon L Mulvagh, Thomas R Porter

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Strom, J. B., Mulvagh, S. L., Porter, T. R., Wei, K., Stout, J. L., & Main, M. L. (2025). Contemporary Safety of Ultrasound Enhancing Agents in a Nationwide Analysis. Journal of the American Heart Association, 14(10). https://doi.org/10.1161/jaha.124.039480

Vancouver

Strom JB, Mulvagh SL, Porter TR, Wei K, Stout JL, Main ML. Contemporary Safety of Ultrasound Enhancing Agents in a Nationwide Analysis. Journal of the American Heart Association. 2025;14(10). doi:10.1161/jaha.124.039480

BibTeX
@article{Strom2025,
  author = {Strom, Jordan B and Mulvagh, Sharon L and Porter, Thomas R and Wei, Kevin and Stout, Jessica L and Main, Michael L},
  title = {Contemporary Safety of Ultrasound Enhancing Agents in a Nationwide Analysis},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {10},
  doi = {10.1161/jaha.124.039480}
}
Kostenlos starten →